Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. Oktober 2021 09:00 ET | Quelle: Laidlaw Venture Partners

Algorithm Sciences, a Laidlaw Venture Partners Portfolio Company, Announces Board Appointments

NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the appointment of Anthony Zook and Gary...
27. Oktober 2020 08:30 ET | Quelle: Laidlaw Venture Partners

Laidlaw Venture Partners Continues Strategic Growth with the Addition of Zachary Shriver, Ph.D. and George Steinfels, Ph.D., MBA as Strategic Advisors for Key Operational Activities

NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Zachary Shriver, Ph.D. and...
20. Oktober 2020 08:30 ET | Quelle: Laidlaw Venture Partners

Laidlaw Venture Partners Continues Strategic Growth with Addition of Paul Korner, MD, MBA and Tony N. Hodges MD FCCP FACP, to its Investment and Operations Committee

NEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of addition of Paul Korner, MD,...
25. August 2020 11:01 ET | Quelle: Laidlaw Venture Partners

Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”

Featuring Michael V. Callahan, MD, MSPH, DTM&H (U.K), Massachusetts General Hospital (MGH) Infectious Disease and Director, Clinical Translation and Mass-Casualty Therapeutics at the Vaccine...